Comerica Bank
MIRM icon

Comerica Bank’s Mirum Pharmaceuticals MIRM Stock Holding History

Comerica Bank’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$53.3K Sell
675
-63
-9% -$4.52K ﹤0.01% 2830
2025
Q3 		$54.1K Sell
738
-29
-4% -$1.84K ﹤0.01% 2801
2025
Q2 		$39K Sell
767
-128
-14% -$5.7K ﹤0.01% 2872
2025
Q1 		$40.3K Buy
895
+278
+45% +$13.1K ﹤0.01% 2848
2024
Q4 		$25.5K Buy
617
+29
+5% +$1.21K ﹤0.01% 2970
2024
Q3 		$22.9K Buy
588
+426
+263% +$17K ﹤0.01% 3008
2024
Q2 		$5.54K Buy
162
+62
+62% +$1.63K ﹤0.01% 3284
2024
Q1 		$2.5K Buy
100
+5
+5% +$137 ﹤0.01% 3490
2023
Q4 		$2.81K Buy
+95
New +$2.88K ﹤0.01% 3447

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Comerica Bank's MIRM Position: Q4 2025 in Review

Comerica Bank reduced its Mirum Pharmaceuticals (MIRM) stake by 8.5% in Q4 2025, selling an estimated $4.52K and leaving 675 shares worth $53.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2830.

Comerica Bank first reported a position in MIRM in Q4 2023 and has held it in 9 quarters since. The position peaked at $54.1K in Q3 2025. 281 funds tracked by Wall St. Rank hold MIRM as of Q4 2025.

  • Comerica Bank held 675 shares of Mirum Pharmaceuticals worth $53.3K as of Q4 2025.
  • Comerica Bank sold 63 Mirum Pharmaceuticals shares in Q4 2025, an estimated $4.52K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2830 holding.
  • Comerica Bank first reported a position in Mirum Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • Comerica Bank's Mirum Pharmaceuticals position peaked at $54.1K in Q3 2025.
  • 281 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.